UTAG 10
10 June 2024UHTA 30
10 June 2024Composition:
Each UTAG tablet contains:
Active ingredient:
- RHODIOLA 30mg
- ESCHOLTZIA 15mg
- PASSIFLORE 15mg
- VALERIANE 15mg
UTAG: Biochemical families and therapeutic properties
Dry Extract | Biochemical Family | Properties | Indications |
---|---|---|---|
Rhodiola 30 mg (120 mg of herb) |
Crassulaceae | Adaptogenic plant Neuroprotective Cardioprotective Antioxidant Anti-hypoxic |
Mild to moderate depression Stress symptoms – Acute fatigue Improves learning and memory Increases physical endurance |
ESCHOLTZIA CALIFORNICA 15 mg (60 mg of herb) |
Papaveraceae | Natural sedative Anxiolytic Analgesic |
Difficulty falling asleep – Night awakenings Restlessness or nervousness Mild to moderate anxiety Analgesic |
PASSIFLORE 15 mg (60 mg of herb) |
Passifloraceae | Anxiolytic (low dose) Sedative (high dose) Antispasmodic |
Mild anxiety Stress Nervous agitation Sleep disorders Muscle spasms Neuralgic pain BZD withdrawal |
VALERIANE 15 mg (60 mg of herb) |
Valerianaceae | Sedative Anxiolytic Anticonvulsant Hypnotic Muscle relaxant |
Sleep disorders Anxiety disorders Restlessness and nervousness |
UTAG: Characteristics
UTAG | BZD |
---|---|
GABAergic action | GABAergic action |
Ache inhibition | Ache inhibition |
Good tolerance | Adverse effects++ |
No dependency induction | Dependency induction |
Supports withdrawal | Withdrawal syndrome |
Be the first to review “UTAG 30” Cancel reply
Reviews
There are no reviews yet.